News for Avidity Biosciences Stock (RNA)

Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Highlights

PRNewsWire • 03/15/21

Biotech Shares Have Soared Since 2020's Wave of IPOs

GuruFocus • 02/17/21

Avidity Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

PRNewsWire • 12/22/20

Avidity Biosciences Announces Addition to the Nasdaq Biotechnology Index

PRNewsWire • 12/21/20

U.S. IPO Week Ahead: DoorDash And Airbnb Kick Off The Unicorn Parade In A 6 IPO Week

Seeking Alpha • 12/06/20

Avidity Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights

PRNewsWire • 11/10/20

Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic Medicines Conference 2020

PRNewsWire • 09/28/20

Avidity Biosciences Enters into Collaboration to Study the Natural History of Myotonic Dystrophy Type 1

PRNewsWire • 09/08/20

Avidity Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights

PRNewsWire • 08/10/20

Avidity Biosciences Appoints Jae Kim, M.D. as Chief Medical Officer

PRNewsWire • 07/27/20

Biotech IPOs are booming -- but it's not all about Covid-19

CNN Business • 06/25/20

Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

PRNewsWire • 06/16/20

Avidity Biosciences jumps 50% in first day of trading

Market Watch • 06/12/20

Avidity Biosciences prices IPO at $18 a share to raise $259.2 million to fund R&D

Market Watch • 06/12/20

Avidity Biosciences Announces Pricing of Initial Public Offering

PRNewsWire • 06/12/20